Sign in

GSK plc

Income Statement - GSK plc (GSK)

$(Billion, Million)
Dec-25 Dec-24 Dec-23 Dec-22 Dec-21 Dec-20 Dec-19 Dec-18 Dec-17 Dec-16 Dec-15 Dec-14 Dec-13 Dec-12 Dec-11 Dec-10 Dec-09 Dec-08 Dec-07 Dec-06
Total revenue 32.67 31.38 30.33 29.32 24.70 24.35 33.75 30.82 30.19 27.89 23.92 23.01 26.51 26.43 27.39 28.39 28.37 24.35 22.74 23.22
Cost of revenue 9.02 9.05 8.57 9.55 8.16 7.93 11.86 10.24 10.34 9.29 8.85 7.32 8.59 7.93 7.65 7.90 7.38 6.42 5.21 5.01
Gross profit 23.65 22.33 21.76 19.77 16.53 16.43 21.89 20.58 19.84 18.60 15.07 15.68 17.92 18.51 19.74 20.49 20.99 17.94 17.53 18.21
Total operating expenses + 15.31 18.31 15.02 13.34 12.18 10.45 14.93 15.10 15.76 16.00 4.75 12.09 10.89 11.21 11.93 16.71 12.56 10.80 9.59 10.40
Operating income 8.34 4.02 6.75 6.43 4.36 5.98 6.96 5.48 4.09 2.60 10.32 3.60 7.03 7.30 7.81 3.78 8.43 7.14 7.94 7.19
Non-operating income (net) -0.94 -0.54 -0.68 -0.81 -0.76 -0.81 -0.74 -0.68 -0.56 -0.66 0.20 -0.63 -0.38 -0.70 -0.11 -0.63 -0.53 -0.48 -0.40 0.29
Income before tax 7.40 3.48 6.06 5.63 3.60 5.17 6.22 4.80 3.53 1.94 10.53 2.97 6.65 6.60 7.70 3.16 7.89 6.66 7.54 7.47
Income tax expense 1.11 0.53 0.76 0.71 0.08 0.07 0.95 0.75 1.36 0.88 2.15 0.14 1.02 1.92 2.24 1.30 2.22 1.95 2.15 2.20
Net income 5.72 2.58 4.93 14.96 4.39 5.75 4.65 3.62 1.53 0.91 8.42 2.76 5.44 4.50 5.26 1.63 5.53 4.60 5.22 5.39
Show Quarterly Income Statement

Income Statement - GSK plc (GSK)

$(Billion, Million)
Mar-26 Dec-25 Sep-25 Jun-25 Mar-25 Dec-24 Sep-24 Jun-24 Mar-24 Dec-23 Sep-23 Jun-23 Mar-23 Dec-22 Sep-22 Jun-22 Mar-22 Dec-21 Sep-21 Jun-21 Mar-21 Dec-20 Sep-20 Jun-20 Mar-20 Dec-19 Sep-19 Jun-19 Mar-19 Dec-18 Sep-18 Jun-18 Mar-18 Dec-17 Sep-17 Jun-17 Mar-17 Dec-16 Sep-16 Jun-16 Mar-16 Dec-15 Sep-15 Jun-15 Mar-15 Dec-14 Sep-14 Jun-14 Mar-14 Dec-13 Sep-13 Jun-13 Mar-13 Dec-12 Sep-12 Jun-12 Mar-12 Dec-11 Sep-11 Jun-11 Mar-11 Dec-10 Sep-10 Jun-10 Mar-10 Dec-09 Sep-09 Jun-09 Mar-09 Dec-08 Sep-08 Jun-08 Mar-08 Dec-07 Sep-07 Jun-07 Mar-07 Dec-06 Sep-06 Jun-06 Mar-06
Total revenue 7.63 8.62 8.55 7.99 7.52 8.12 8.01 7.88 7.36 8.05 8.15 7.18 6.95 7.38 7.83 6.93 7.19 9.53 6.63 5.84 7.42 8.74 8.65 7.62 9.09 8.90 9.39 7.81 7.66 8.20 8.09 7.31 7.22 7.64 7.84 7.32 7.38 7.59 7.54 6.53 6.23 6.29 6.13 5.89 5.62 6.19 5.65 5.56 5.61 6.91 6.51 6.62 6.47 6.80 6.53 6.46 6.64 6.98 7.10 6.72 6.59 7.20 6.81 7.03 7.36 8.09 6.76 6.75 6.77 6.91 5.88 5.87 5.69 6.00 5.48 5.67 5.59 5.95 5.64 5.81 5.81
Cost of revenue 1.88 2.66 2.26 2.17 1.94 2.56 2.40 2.12 1.97 2.42 2.27 1.93 1.94 2.24 2.42 2.18 2.72 3.68 2.02 1.71 2.48 3.17 2.89 2.45 3.20 3.25 3.25 2.64 2.73 2.90 2.64 2.31 2.39 2.56 2.65 2.62 2.51 2.51 2.53 2.12 2.13 2.54 2.20 2.01 2.10 2.03 1.83 1.72 1.74 2.53 2.11 1.97 1.98 2.01 2.09 2.00 1.82 1.90 2.08 1.74 1.87 2.08 1.91 1.66 1.95 2.12 1.78 1.69 1.79 1.95 1.59 1.51 1.36 1.53 1.23 1.21 1.23 1.44 1.22 1.21 1.13
Gross profit 5.75 5.96 6.29 5.82 5.58 5.56 5.62 5.76 5.39 5.63 5.88 5.25 5.01 5.14 5.41 4.75 4.47 5.85 4.61 4.13 4.94 5.57 5.76 5.18 5.89 5.65 6.14 5.17 4.93 5.29 5.46 5.00 4.83 5.08 5.19 4.70 4.87 5.08 5.02 4.41 4.10 3.75 3.92 3.88 3.52 4.16 3.82 3.84 3.87 4.38 4.40 4.65 4.50 4.79 4.44 4.46 4.82 5.08 5.02 4.98 4.71 5.12 4.91 5.37 5.41 5.98 4.98 5.06 4.98 4.96 4.29 4.36 4.33 4.46 4.24 4.46 4.36 4.51 4.42 4.60 4.67
Total operating expenses + 3.46 4.46 3.70 3.80 3.36 4.86 5.43 4.12 3.90 5.06 3.93 3.11 2.93 3.27 4.22 3.67 2.18 4.95 3.23 2.86 3.25 4.51 3.90 2.33 3.88 3.75 3.99 3.69 3.50 3.74 3.55 4.22 3.59 4.57 3.31 4.72 3.15 4.48 3.59 4.56 3.37 4.00 2.90 3.55 -5.70 3.47 3.11 2.70 2.80 1.94 2.83 3.21 2.92 2.85 2.78 2.75 2.81 3.20 2.91 3.20 2.68 5.44 2.95 5.32 3.31 3.53 2.91 2.86 3.27 3.38 2.64 2.42 2.36 2.53 4.19 2.53 2.19 2.81 2.40 2.69 2.50
Operating income 2.29 1.51 2.59 2.02 2.22 0.70 0.19 1.65 1.49 0.57 1.95 2.14 2.08 1.87 1.19 1.08 2.29 0.90 1.38 1.28 1.69 1.06 1.86 2.85 2.01 1.90 2.15 1.48 1.43 1.55 1.91 0.78 1.24 0.51 1.88 -0.02 1.72 0.60 1.43 -0.15 0.72 -0.25 1.03 0.34 9.22 0.69 0.70 1.14 1.07 2.44 1.57 1.44 1.58 1.94 1.66 1.71 2.01 1.88 2.12 1.78 2.04 -0.32 1.96 0.05 2.09 2.45 2.07 2.20 1.71 1.58 1.66 1.94 1.96 3.79 1.91 1.93 2.17 1.70 2.02 1.91 2.17
Non-operating income (net) -0.15 -0.56 -0.14 -0.14 -0.11 -0.13 -0.13 -0.15 -0.14 -0.19 -0.16 -0.15 -0.18 -0.24 -0.18 -0.19 -0.20 -0.19 -0.19 -0.21 -0.18 -0.24 -0.19 -0.21 -0.18 -0.19 -0.20 -0.22 -0.13 -0.18 -0.21 -0.17 -0.13 -0.07 -0.17 -0.16 -0.17 -0.17 -0.16 -0.17 -0.16 -0.16 -0.16 -0.18 0.71 -0.16 -0.16 -0.15 -0.16 0.11 -0.17 -0.15 -0.17 -0.19 -0.17 -0.18 -0.16 -0.18 -0.17 -0.19 0.43 -0.16 -0.16 -0.15 -0.16 -0.20 -0.16 -0.13 -0.05 -0.19 -0.10 -0.10 -0.09 -2.18 -0.03 -0.03 -0.02 0.01 0.00 -0.01 0.00
Income before tax 2.14 0.95 2.46 1.89 2.11 0.56 0.06 1.50 1.36 0.38 1.79 1.99 1.91 1.63 1.01 0.90 2.09 0.71 1.19 1.07 1.52 0.82 1.67 2.64 1.84 1.71 1.95 1.26 1.30 1.37 1.71 0.61 1.11 0.44 1.71 -0.18 1.55 0.42 1.27 -0.32 0.56 -0.42 0.87 0.15 9.92 0.53 0.55 0.99 0.90 2.55 1.40 1.29 1.41 1.75 1.49 1.53 1.86 1.70 1.94 1.59 2.46 -0.48 1.80 -0.10 1.93 2.25 1.91 2.06 1.67 1.40 1.55 1.84 1.87 1.62 1.88 1.90 2.14 1.71 2.02 1.90 2.17
Income tax expense 0.31 0.22 0.31 0.24 0.34 0.06 0.00 0.19 0.27 -0.02 0.26 0.24 0.28 0.00 0.23 0.15 0.32 -0.22 0.25 -0.20 0.26 -0.02 0.24 0.20 0.16 0.19 0.24 0.21 0.31 0.07 0.19 0.14 0.35 0.81 0.32 -0.09 0.33 0.11 0.39 0.17 0.21 0.01 0.22 0.04 1.89 -0.49 0.16 0.28 0.18 0.04 0.39 0.20 0.38 0.91 0.31 0.23 0.48 0.42 0.50 0.45 0.88 0.16 0.46 0.16 0.54 0.58 0.54 0.60 0.50 0.38 0.50 0.53 0.54 0.53 0.54 0.54 0.61 0.50 0.60 0.56 0.64
Net income 1.74 0.64 2.01 1.44 1.62 0.41 -0.06 1.17 1.05 0.35 1.46 1.62 1.49 1.46 10.82 0.84 1.80 0.75 1.37 1.40 1.07 0.68 1.24 2.26 1.57 1.30 1.55 0.96 0.83 1.22 1.42 0.44 0.55 -0.55 1.21 -0.18 1.05 0.26 0.81 -0.44 0.28 -0.35 0.54 0.15 8.09 1.03 0.40 0.65 0.67 2.46 0.97 1.05 0.96 0.86 1.11 1.24 1.31 1.25 1.38 1.11 1.53 -0.69 1.29 -0.30 1.34 1.63 1.34 1.44 1.13 1.02 1.03 1.29 1.31 1.06 1.31 1.33 1.51 1.18 1.39 1.32 1.50
about 2 months ago

Balance Sheet - GSK plc (GSK)

$(Billion, Million)
Dec-25 Dec-24 Dec-23 Dec-22 Dec-21 Dec-20 Dec-19 Dec-18 Dec-17 Dec-16 Dec-15 Dec-14 Dec-13 Dec-12 Dec-11 Dec-10 Dec-09 Dec-08 Dec-07 Dec-06
Total cash and short-term investments + 3.40 3.71 6.61 7.88 5.87 8.71 6.34 3.96 3.91 4.99 5.91 4.41 5.60 4.27 5.90 6.33 6.94 6.01 4.53 3.04
Accounts receivable, net 7.75 6.00 9.44 6.22 10.88 9.93 9.47 6.32 5.95 5.92 3.88 4.49 5.15 5.06 5.32 5.59 6.25 6.27 5.56 5.50
Inventories 5.91 5.67 7.01 5.15 7.83 8.20 7.88 5.48 5.56 5.10 4.72 4.23 3.90 3.97 3.87 3.84 4.06 4.06 3.06 2.44
Other current assets 0.42 1.62 0.72 1.45 0.71 0.84 2.13 1.17 6.44 6.62 5.97 6.04 0.58 0.40 1.08 0.27 0.32 0.08 0.00 0.01
Total current assets 17.48 17.00 23.77 20.77 25.29 27.68 25.82 16.93 15.91 16.71 16.59 14.68 15.23 13.69 16.17 16.04 17.57 17.27 13.63 10.99
Total non-current assets + 43.53 42.47 51.45 39.38 81.85 82.27 79.75 41.14 40.47 42.37 36.86 25.97 26.86 27.78 24.91 26.02 25.29 22.12 17.38 14.56
Total assets 61.01 59.46 75.22 60.15 107.14 109.95 105.57 58.07 56.38 59.08 53.45 40.65 42.09 41.48 41.08 42.05 42.86 39.39 31.00 25.55
Total current liabilities + 21.35 21.70 26.86 22.81 32.06 30.28 31.86 22.49 26.57 19.00 13.42 13.30 13.68 13.82 15.01 12.62 12.12 10.02 10.35 7.27
Total non-current liabilities + 23.66 24.68 32.05 27.24 46.17 51.23 49.39 31.90 26.32 35.12 31.15 22.42 20.60 20.91 17.24 19.69 20.00 21.06 10.75 8.64
Total liabilities 45.02 46.38 58.91 50.05 78.23 81.50 81.25 54.39 52.89 54.12 44.57 35.72 34.27 34.73 32.25 32.31 32.12 31.08 21.09 15.91
Total stockholders' equity + 16.35 13.67 17.01 10.60 20.39 19.94 15.11 3.78 3.49 4.96 8.88 4.94 7.00 5.81 8.03 8.89 10.01 7.93 9.60 9.39
Common shares outstanding 1,029 2,071 2,056 2,042 1,621 2,015 2,006 1,988 1,976 1,964 1,955 1,946 1,968 1,996 2,040 2,051 2,043 2,090 2,227 2,283
Show Quarterly Balance Sheet

Balance Sheet - GSK plc (GSK)

$(Billion, Million)
Mar-26 Dec-25 Sep-25 Jun-25 Mar-25 Dec-24 Sep-24 Jun-24 Mar-24 Dec-23 Sep-23 Jun-23 Mar-23 Dec-22 Sep-22 Jun-22 Mar-22 Dec-21 Sep-21 Jun-21 Mar-21 Dec-20 Sep-20 Jun-20 Mar-20 Dec-19 Sep-19 Jun-19 Mar-19 Dec-18 Sep-18 Jun-18 Mar-18 Dec-17 Sep-17 Jun-17 Mar-17 Dec-16 Sep-16 Jun-16 Mar-16 Dec-15 Sep-15 Jun-15 Mar-15 Dec-14 Sep-14 Jun-14 Mar-14 Dec-13 Sep-13 Jun-13 Mar-13 Dec-12 Sep-12 Jun-12 Mar-12 Dec-11 Sep-11 Jun-11 Mar-11 Dec-10 Sep-10 Jun-10 Mar-10 Dec-09 Sep-09 Jun-09 Mar-09 Dec-08 Sep-08 Jun-08 Mar-08 Dec-07 Sep-07 Jun-07 Mar-07 Dec-06 Sep-06 Jun-06 Mar-06
Total cash and short-term investments + 4.54 3.40 4.45 4.96 5.79 3.71 3.21 3.77 5.17 6.61 8.16 8.27 8.62 7.88 7.99 7.93 10.37 5.87 4.74 4.92 6.65 8.71 5.64 10.20 6.02 6.34 4.39 4.21 4.21 3.96 3.87 4.13 4.08 3.91 4.83 4.07 4.60 4.99 4.70 4.67 4.49 5.91 5.98 7.62 10.36 4.41 4.17 3.23 3.58 5.60 3.32 2.91 3.92 4.27 3.62 7.59 5.84 5.90 5.58 6.01 6.67 6.33 6.66 6.93 7.31 6.94 7.03 5.92 6.84 6.87 5.55 5.38 3.37 4.54 3.13 2.92 2.99 3.04 3.39 4.78 5.78
Accounts receivable, net 10.47 7.75 11.18 10.55 9.68 6.00 7.38 9.83 9.21 9.44 10.83 9.02 8.81 6.22 9.04 8.34 9.82 10.88 11.17 10.37 9.91 9.93 10.89 9.26 11.03 9.47 8.17 6.88 6.55 25.64 7.29 6.56 6.11 4.67 6.49 6.20 6.22 5.69 7.10 5.84 5.85 5.49 5.91 5.31 5.50 3.56 5.07 5.00 5.32 3.97 5.21 5.58 5.67 5.06 5.61 5.57 5.59 5.99 6.02 6.81 6.49 6.05 5.36 5.92 6.27 5.48 5.39 5.32 5.56 5.03 5.06 5.12 5.28 0.76 4.99 5.34
Inventories 8.12 5.91 8.24 8.32 7.74 5.67 5.92 7.41 7.20 7.01 6.69 7.01 6.62 5.15 5.20 5.66 6.78 7.83 8.42 8.74 8.58 8.20 8.33 7.90 7.38 7.88 6.78 5.96 5.68 5.48 5.79 5.94 5.66 5.56 5.66 5.74 5.42 5.10 5.37 5.49 5.14 4.72 4.85 4.80 4.58 4.23 4.27 4.11 4.09 3.90 4.17 4.14 4.20 3.97 4.04 3.96 4.01 3.87 4.04 4.27 4.04 3.84 4.07 4.07 4.16 4.06 4.19 3.91 4.11 4.06 3.52 3.53 3.31 3.06 2.97 2.76 2.55 2.44 2.49 2.40 2.35
Other current assets 0.30 0.42 0.15 0.39 0.13 1.62 0.79 0.18 0.15 0.72 0.25 0.30 0.32 1.45 0.37 43.87 0.38 0.71 0.29 0.23 0.42 0.84 0.85 1.03 2.88 2.13 1.65 1.19 1.08 7.49 0.47 0.42 0.58 1.70 0.68 0.42 0.55 0.74 0.44 0.87 0.35 0.36 0.24 0.39 0.43 2.48 1.35 1.22 0.25 1.76 0.78 0.80 0.33 0.38 0.23 5.71 6.43 0.82 6.77 6.03 6.10 0.27 0.07 0.06 0.08 0.07 0.07 0.06 0.10 0.08 0.41 0.38 0.53 0.48 0.25 0.24 0.19 0.23 5.26 0.48 5.82
Total current assets 23.42 17.48 24.02 24.22 23.34 17.00 17.30 21.19 21.73 23.77 25.92 24.60 24.38 20.77 22.60 65.81 27.35 25.29 24.61 24.27 25.56 27.68 25.70 28.39 27.31 25.82 20.99 18.23 17.52 16.93 17.42 17.04 16.42 15.91 17.66 16.43 16.79 16.71 17.61 16.88 15.83 16.59 16.98 18.12 20.86 14.68 14.86 13.55 13.25 15.23 13.47 13.44 14.12 13.69 13.49 17.26 16.28 16.17 16.39 16.31 16.80 16.04 16.79 17.08 18.36 17.57 17.34 15.25 16.97 17.27 14.95 14.68 12.53 13.64 11.38 10.97 10.86 10.99 11.89 12.65 13.94
Total non-current assets + 59.48 43.53 58.56 56.99 55.01 42.47 40.75 52.21 52.18 51.45 48.36 51.00 48.07 39.38 44.72 42.33 51.85 81.85 81.49 82.12 82.17 82.27 78.92 76.19 77.32 79.75 62.26 45.40 44.84 41.14 41.19 40.59 39.74 40.47 41.13 41.81 42.45 42.37 41.18 40.75 38.65 36.86 36.14 36.00 37.13 25.97 25.44 25.30 26.46 26.86 27.64 28.62 28.78 27.78 26.96 25.19 24.52 24.91 25.02 25.77 25.78 26.19 25.86 25.97 26.20 25.29 24.11 20.71 22.20 22.12 18.91 17.84 17.82 17.39 16.29 15.86 15.52 14.56 13.96 13.84 14.03
Total assets 82.91 61.01 82.58 81.20 78.35 59.46 58.05 73.40 73.91 75.22 74.29 75.60 72.45 60.15 67.33 108.14 79.19 107.14 106.10 106.39 107.73 109.95 104.62 104.58 104.63 105.57 83.25 63.63 62.37 58.07 58.60 57.64 56.16 56.38 58.78 58.23 59.24 59.08 58.79 57.63 54.48 53.45 53.12 54.12 58.00 40.65 40.30 38.85 39.71 42.09 41.11 42.06 42.89 41.48 40.45 42.46 40.80 41.08 41.41 42.08 42.58 42.23 42.65 43.05 44.56 42.86 41.45 35.96 39.17 39.39 33.86 32.52 30.36 31.03 27.67 26.83 26.38 25.54 25.85 26.49 27.98
Total current liabilities + 29.58 21.35 28.72 27.92 26.89 21.70 21.46 25.72 25.07 26.86 27.33 28.11 25.59 22.81 23.39 45.95 30.03 32.06 30.23 29.55 27.97 30.28 28.67 29.56 31.41 31.86 25.51 25.78 24.46 22.49 18.40 18.20 26.93 26.57 27.44 28.79 18.76 19.00 18.14 18.11 13.92 13.42 12.75 13.80 15.79 13.30 15.27 12.25 11.67 13.68 12.83 12.48 12.01 13.82 13.96 15.40 14.53 15.01 13.11 13.62 13.11 12.79 11.24 12.00 12.15 12.12 11.12 9.03 9.75 10.02 8.80 8.27 9.28 10.36 9.03 7.21 7.44 7.26 7.29 8.25 9.35
Total non-current liabilities + 30.35 23.66 32.65 33.61 33.84 24.68 23.14 30.28 32.13 32.05 31.55 32.03 32.87 27.24 34.21 34.70 35.87 46.17 46.55 47.03 50.76 51.23 49.29 50.14 48.30 49.39 39.67 34.89 34.53 31.90 36.49 36.41 25.64 26.32 26.52 25.02 34.89 35.12 36.65 35.29 34.02 31.15 31.04 29.77 30.80 22.42 19.28 19.76 20.61 20.60 21.48 22.31 23.27 20.91 13.33 19.26 16.69 17.24 20.07 19.02 19.58 19.69 20.79 21.51 20.98 20.00 20.69 18.90 20.99 21.06 17.27 16.55 11.87 10.76 8.48 8.58 8.77 8.64 9.16 9.21 9.58
Total liabilities 59.93 45.02 61.37 61.53 60.73 46.38 44.60 55.99 57.20 58.91 58.88 60.14 58.46 50.05 57.60 80.65 65.90 78.23 76.78 76.58 78.74 81.50 77.96 79.70 79.71 81.25 65.19 60.67 58.99 54.39 54.88 54.61 52.57 52.89 53.95 53.81 53.64 54.12 54.79 53.40 47.94 44.57 43.79 43.57 46.59 35.72 34.55 32.01 32.28 34.27 34.31 34.79 35.28 34.73 33.43 34.66 31.23 32.25 33.18 32.64 32.69 32.49 32.04 33.51 33.13 32.12 31.81 27.93 30.73 31.08 26.06 24.82 21.15 21.11 17.51 15.79 16.21 15.90 16.45 17.45 18.92
Total stockholders' equity + 23.54 16.35 21.74 20.27 18.27 13.67 14.01 18.17 17.48 17.01 16.03 16.13 14.61 10.60 10.22 19.89 13.95 20.39 20.80 21.24 20.51 19.94 18.47 16.80 16.24 15.11 11.77 3.61 4.01 4.36 4.48 3.68 -0.07 -0.07 1.29 0.81 1.71 1.12 0.14 0.57 2.81 5.11 5.43 6.82 7.43 4.26 5.04 6.12 6.62 7.00 5.97 6.41 6.69 5.81 6.22 7.05 8.78 8.03 7.44 8.68 9.07 8.89 9.81 8.77 10.67 10.01 9.28 7.72 8.06 7.93 7.49 7.44 8.92 9.61 9.88 10.80 9.94 9.38 9.16 8.82 8.82
Common shares outstanding 2,037 1,022 2,051 2,055 2,069 2,073 2,040 2,061 2,057 2,059 2,056 2,047 2,043 2,046 2,044 2,032 2,033 2,038 2,027 2,019 2,015 2,017 2,016 2,009 2,004 2,009 2,003 1,996 1,991 1,991 1,989 1,984 1,978 1,956 1,974 1,955 1,967 1,966 1,961 1,944 1,956 1,935 1,951 1,950 1,944 1,944 1,946 1,950 1,946 1,952 1,969 1,967 1,939 1,965 1,989 1,998 2,014 2,010 2,024 2,048 2,056 2,034 2,050 2,050 2,050 2,028 2,043 2,043 2,043 2,044 2,058 2,109 2,160 2,220 2,239 2,240 2,265 2,240 2,262 2,291 2,288
about 2 months ago

Cash Flow - GSK plc (GSK)

$(Billion, Million)
Dec-25 Dec-24 Dec-23 Dec-22 Dec-21 Dec-20 Dec-19 Dec-18 Dec-17 Dec-16 Dec-15 Dec-14 Dec-13 Dec-12 Dec-11 Dec-10 Dec-09 Dec-08 Dec-07 Dec-06
Operating cash flow + 7.14 6.55 7.89 7.40 7.95 8.44 8.02 8.42 6.92 6.50 2.57 5.18 7.22 4.38 6.25 6.80 7.84 7.31 6.17 4.08
Cash flow from investing + -5.72 -1.23 -2.40 -8.77 -1.78 2.16 -5.35 -1.55 -1.44 -1.27 6.04 -1.08 0.52 -2.63 -0.11 -1.87 -4.01 -2.07 -3.01 -1.76
Cash flow from financing + -1.59 -4.73 -6.07 0.82 -7.59 -10.13 -1.84 -6.39 -6.38 -6.39 -7.10 -5.39 -6.27 -3.35 -6.23 -5.57 -2.77 -3.44 -1.74 -4.19
Change in cash -0.17 0.60 -0.58 -0.55 -1.41 0.47 0.83 0.48 -0.91 -1.16 1.50 -1.29 1.47 -1.61 -0.09 -0.64 1.05 1.79 1.41 -1.87
Change in exchange rate 0.00 0.00 0.00 0.00 0.00
Show Quarterly Cash Flow

Cash Flow - GSK plc (GSK)

$(Billion, Million)
Mar-26 Dec-25 Sep-25 Jun-25 Mar-25 Dec-24 Sep-24 Jun-24 Mar-24 Dec-23 Sep-23 Jun-23 Mar-23 Dec-22 Sep-22 Jun-22 Mar-22 Dec-21 Sep-21 Jun-21 Mar-21 Dec-20 Sep-20 Jun-20 Mar-20 Dec-19 Sep-19 Jun-19 Mar-19 Dec-18 Sep-18 Jun-18 Mar-18 Dec-17 Sep-17 Jun-17 Mar-17 Dec-16 Sep-16 Jun-16 Mar-16 Dec-15 Sep-15 Jun-15 Mar-15 Dec-14 Sep-14 Jun-14 Mar-14 Dec-13 Sep-13 Jun-13 Mar-13 Dec-12 Sep-12 Jun-12 Mar-12 Dec-11 Sep-11 Jun-11 Mar-11 Dec-10 Sep-10 Jun-10 Mar-10 Dec-09 Sep-09 Jun-09 Mar-09 Dec-08 Sep-08 Jun-08 Mar-08 Dec-07 Sep-07 Jun-07 Mar-07 Dec-06 Sep-06 Jun-06 Mar-06
Operating cash flow + 1.14 2.04 3.03 2.10 1.15 2.33 2.15 1.11 1.19 3.62 2.21 1.31 0.05 1.91 1.45 1.64 2.54 4.70 3.50 1.35 0.33 4.63 0.86 2.76 0.97 3.45 2.52 1.39 0.66 4.12 2.08 1.36 0.86 2.87 1.90 1.01 1.14 2.99 1.77 1.24 0.50 1.50 0.48 0.22 0.37 2.21 1.27 0.77 0.93 2.19 2.08 1.71 1.25 1.91 -0.29 1.74 1.01 2.15 1.83 1.29 0.99 1.47 1.09 2.12 2.12 2.26 2.08 1.76 1.74 2.14 1.89 1.37 1.80 1.66 1.74 1.24 1.53 1.74 -0.11 1.04 1.70
Cash flow from investing + -1.47 -2.36 -2.15 -0.63 -1.14 -1.12 -0.73 0.77 -0.25 0.29 -0.49 -0.96 -0.41 -8.77 -5.01 -0.55 -3.59 -0.47 -1.65 -0.27 -0.05 -0.04 -0.56 2.83 -0.06 -0.37 -0.47 -0.56 -3.95 -0.41 -0.51 -0.26 -0.37 -0.34 -0.46 -0.45 -0.20 -0.17 -0.17 -0.25 -0.67 -0.43 -0.17 -0.46 7.09 -0.38 -0.22 -0.15 -0.33 1.83 -0.53 -0.48 -0.30 -0.24 -2.41 -0.12 0.13 -0.46 -0.23 -0.25 0.84 -0.55 -0.48 -0.51 -0.32 -0.71 -2.40 -0.24 -0.67 0.03 -0.23 0.11 -0.25 -1.35 -0.36 -0.32 -0.96 -0.64 -0.53 -0.18 -0.17
Cash flow from financing + 0.27 0.81 -1.71 -2.37 0.86 -0.84 -1.24 -1.58 -1.25 -4.06 -1.76 0.03 -0.32 -1.34 -1.75 -4.49 7.97 -3.33 -1.87 -2.40 -1.38 -2.53 -4.28 -2.63 -1.05 -2.76 -1.85 -0.89 3.66 -3.25 -1.67 -1.19 -0.28 -3.26 -0.65 -0.97 -1.51 -1.94 -1.97 -1.17 -1.31 -0.97 -2.02 -2.34 -1.78 -1.66 -0.18 -0.95 -2.59 -1.62 -1.10 -2.10 -1.46 -1.02 -1.21 0.11 -1.23 -1.29 -1.86 -1.77 -1.31 -1.02 -0.88 -2.06 -1.62 -1.30 1.32 -2.14 -0.65 -2.33 -1.96 1.39 -2.81 1.19 -1.27 -1.01 -0.65 -1.30 -0.91 -1.59 -1.00
Change in cash -0.05 0.48 -0.83 -0.90 0.86 0.37 0.18 0.30 -0.32 -0.15 -0.04 0.37 -0.67 -8.21 -5.30 -3.40 6.92 0.90 -0.02 -1.32 -1.09 2.06 -3.98 2.96 -0.15 0.32 0.20 -0.07 0.37 0.46 -0.10 -0.09 0.21 -0.72 0.79 -0.40 -0.56 0.87 -0.37 -0.19 -1.48 0.11 -1.71 -2.58 5.68 0.17 0.88 -0.34 -2.00 2.40 0.45 -0.87 -0.51 0.66 -3.91 1.73 -0.09 0.39 -0.26 -0.74 0.51 -0.11 -0.26 -0.45 0.18 0.25 1.00 -0.61 0.42 -0.16 -0.30 2.87 -1.26 1.50 0.11 -0.09 -0.08 -0.20 -1.55 -0.74 0.53
Change in exchange rate 0.00 0.00 0.00 0.00 0.00 0.00
about 2 months ago

GSK plc (GSK) - Capital Expenditures

1Y 2Y 5Y Max
about 2 months ago

GSK plc (GSK) - Depreciation Depletion And Amortization

1Y 2Y 5Y Max
about 2 months ago

GSK plc (GSK) - Operating Cashflow

1Y 2Y 5Y Max
about 2 months ago

GSK plc (GSK) - Change In Exchange Rate

1Y 2Y 5Y Max
about 2 months ago

GSK plc (GSK) - Change In Cash And Cash Equivalents

1Y 2Y 5Y Max
about 2 months ago

GSK plc (GSK) - Net Income

1Y 2Y 5Y Max
about 2 months ago

GSK plc (GSK) - Stock Based Compensation

1Y 2Y 5Y Max
about 2 months ago

GSK plc (GSK) - Proceeds From Repurchase Of Equity

1Y 2Y 5Y Max
about 2 months ago

GSK plc (GSK) - Dividend Payout

1Y 2Y 5Y Max
about 2 months ago

GSK plc (GSK) - Cashflow From Financing

1Y 2Y 5Y Max
about 2 months ago